Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
236 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Show all (1)
  • (-) Closed (1)

Medical Condition

  • Show all (32)
  • Autoimmune Disorders (3)
  • Blood Disorders (2)
  • Cancer (6)
    • Kidney Cancer (2)
    • (-) Solid Tumors (1)
  • Healthy Volunteers (1)
  • Heart Disease (2)
  • Kidney Disease (12)
  • Liver Disease (2)
  • Lung Disease (1)
  • Neurological Disorders (1)
  • Transplant (1)
  • Vascular Conditions (1)
Displaying 1 - 1 of 1

Study of TSR-042 (anti-PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors

Condition: Cancer / Solid Tumors
Investigator: June Hou, MD
Status: Closed
The study drug (TSR-042) in this study is designed to stop cancer from growing by helping your immune system recognize and fight the cancer. The Study Drug is designed to help your immune system by attaching to a protein called PD-1 and stopping one of the signals that keeps your immune system from recognizing the cancer. This may help your immune system…
Read More
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Terms of Use Privacy Policy ©2026 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science